Home Products About Us Contact Us Events Press About Apnea Testimonials Dealers
fdgdsf
InnoMed Technologies ``New Era in CPAP Therapy'' Now Available to the Homecare Market
Date: 08/12/2004
BOCA RATON, Fla.--(BUSINESS WIRE)--
InnoMed Technologies, Inc.
has introduced the Nasal-PAP Freestyle, its new CPAP interface. The
Nasal-Pap Freestyle, which does not touch the face, is a dramatic departure
from anything on the market and it is available in seven sizes to
accommodate the broadest sector of CPAP users.
"The Nasal-PAP Freestyle is the simplest most innovative piece of CPAP
equipment I have seen in my 15 years in this industry," said InnoMed C.E.O.,
R. Patrick Karem. "But, it is only one offering in our continually growing
and industry leading interface product line."
The Nasal-Pap Freestyle was unveiled with wide acclaim at the AARC Conference in Las Vegas in November creating a great deal of demand for the product. It is now available to the homecare market.
Thomas J. Wood, the inventor of the Nasal-PAP Freestyle as well as the world renowned Nasal-Aire(R) interface, said, "This is one of the best CPAP interfaces on the market because of the high degree of linear flow throughout the system."
About InnoMed Technologies
InnoMed Technologies, Inc., is a research-oriented, privately held, 21st
Century medical technologies company. The company is poised to bring new and
more effective medical products and devices to the public through a medical
development and engineering team, as well as acquisitions of other medical
related companies. InnoMed holds several patents and has several patents
pending. More information regarding InnoMed Technologies is available at
http://www.innomedinc.com.
A Private Securities Reform Act of 1995 provides a 'safe harbor' for forward-looking statements. Certain information included in this press release (as well as information included in written statements to be made) contain statements that are forward-looking, such as those relating to consummation of the transaction, anticipated future revenue of the Company, and success of current public offerings. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward looking statements.